0001474064-12-000007.txt : 20120119
0001474064-12-000007.hdr.sgml : 20120119
20120119160902
ACCESSION NUMBER: 0001474064-12-000007
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120117
FILED AS OF DATE: 20120119
DATE AS OF CHANGE: 20120119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Selisker Rachel R
CENTRAL INDEX KEY: 0001313793
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23272
FILM NUMBER: 12534776
MAIL ADDRESS:
STREET 1: 550 HILLS DRIVE
STREET 2: 3RD FLOOR
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000890465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 870439579
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 550 HILLS DRIVE
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
BUSINESS PHONE: (908) 450-5300
MAIL ADDRESS:
STREET 1: 550 HILLS DRIVE
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
4
1
edgar.xml
PRIMARY DOCUMENT
X0304
4
2012-01-17
0000890465
NPS PHARMACEUTICALS INC
NPSP
0001313793
Selisker Rachel R
550 HILLS DRIVE
BEDMINSTER
NJ
07921
1
0
0
0
Deferred Stock Units
2012-01-17
4
A
0
2278
0
A
Common Stock
2278
144074
D
Each Deferred Stock Unit represents a right to receive one share of NPS Common Stock.
Deferred Stock Units awarded under the NPS Pharmaceuticals, Inc. 2007 Nonemployee Directors' Compensation Program will be settled in NPS Common Stock upon (1) separation from service on the Board, (2) death, (3) disability, or (4) sale of substantially all the assets of the Company.
/s/ Edward Stratemeier as Attorney-in-Fact
2012-01-19